Tashkin, D P <br/><br/>
The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease.  [electronic resource] 

 -  Expert opinion on drug safety  2015 
 - 1759-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-764X 
<br/><br/><label>Standard No.: </label>10.1517/14740338.2015.1093621  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bronchodilator Agents--administration & dosage<br/>Cardiotoxicity--etiology<br/>Cholinergic Antagonists--administration & dosage<br/>Delayed-Action Preparations<br/>Humans<br/>Ipratropium--administration & dosage<br/>Muscarinic Antagonists--administration & dosage<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Randomized Controlled Trials as Topic